Media Kit

Thank you for your interest in Veyond Metaverse. Here are some resources to help you out.

Company Overview

At Veyond Metaverse, we are innovating the field of healthcare, with a particular emphasis on surgical training. We understand the barriers currently faced in the medical sector, including geographical limitations, outdated training methods, and accessibility issues. Our advanced communication platform, Veyond Connect™, is designed to address these pain points by reshaping medical education, surgical training, and patient treatment.

NAME

Veyond Metaverse

YEAR OF INCORPORATION

2021

COUNTRY OF ORIGIN

USA

LOCATION

San Francisco, CA

SUMMARY

Veyond Metaverse is a digital healthcare technology company that is revolutionizing the way medical education, surgical training, and patient treatments are conducted.

PRODUCT

Veyond Connect, Veyond Metaverse’s flagship product, is a 3D photorealistic immersive telepresence platform. It leverages Extended Reality (XR) and digital twin technologies to connect medical practitioners from different parts of the world.

Our Achievements

Surgical Training Revolution

Launched the first XR Surgical training center with Veyond Connect™ technology in Latin America, leading the way for global adoption.

Haptic Capability Validation

Achieved an unprecedented level of tactile feedback in digital surgeries in partnership with Teslasuit, Senseglove, and neurosurgeons from London, Ontario.

Dynamic Digital Twin Development

Transitioned from static to dynamic digital twins in partnership with French firms Vygon and Landanger, underlining our commitment to technological evolution.

AI-driven Translation

Successfully implemented AI-driven NLP real-time translation within Veyond Connect™, ensuring seamless communication across global medical teams.

Global Platform Validation

Successfully integrated digital twins into the Veyond Connect XR platform and conducted field testing across various countries.

Successful Prototyping and POC Testing

Tested our prototype successfully in a brain surgery procedure and conducted successful POC testing with KITECH in Korea and Rapid Diagnostics in Latin America.